key: cord-293964-hz5uow2b
authors: Hermann, Matthias; Pekacka-Egli, Anna-Maria; Witassek, Fabienne; Baumgaertner, Reiner; Schoendorf, Sabine; Spielmanns, Marc
title: Feasibility and Efficacy of Cardiopulmonary Rehabilitation following COVID-19
date: 2020-07-22
journal: Am J Phys Med Rehabil
DOI: 10.1097/phm.0000000000001549
sha: 
doc_id: 293964
cord_uid: hz5uow2b

The COVID-19 pandemic affects a large number of patients with a rapid progression of respiratory failure often requiring hospitalization or intensive care unit treatment in some patients. Survivors of severe COVID-19 suffer from persistent weakness and cardiorespiratory failure. Feasibility and potential benefit of cardiopulmonary rehabilitation (CR) after COVID-19 remains unclear. Therefore, we retrospectively analyzed a cohort of COVID-19 patients in a single center inpatient rehabilitation clinic and describe performance and outcome during CR. Patients were referred from acute care hospitals for rehabilitation after severe COVID-19. The cohort (n=28) was divided in ventilated or not ventilated patients for further analysis. 50% were female, mean age was 66 years and patients stayed in the acute hospital for 19.3±10.7 days before referral for CR. 17 patients (61%) needed previous ICU treatment in the acute care hospital. Risk factors, assessments and questionnaires on admission were comparable in both groups. Significant enhancements were observed in 6-minute walking test and Feeling Thermometer which were independent of previous ventilation status. In conclusion, comprehensive CR following COVID-19 is safe, feasible and effective. Improvements in physical performance and subjective health status were independent of previous ventilation.

Infection with the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2), hereafter referred as COVID-19, often affects patients with chronic health conditions and takes a more severe course in patients with comorbidities such as cardiovascular disease, diabetes mellitus, and obesity. 1 A feature of severe COVID-19 is the rapid progression of respiratory failure often requiring hospitalization or even intensive care unit (ICU) treatment. 2 Severe outcome of COVID-19 is particular driven by a so called systemic endotheliitis, a severe cytokine storm and activated coagulation and mortality of severe COVID-19 is high. 3, 4 Survivors suffer from reduced lung function, critical illness polyneuropathy and myopathy and cardiorespiratory deconditioning that could be described as a form of Post Intensive Care Unit Syndrome (PICS). 5, 6 Survivors of severe COVID-19 are significantly impaired in all activities of daily living and are in need of multimodal rehabilitation with particular knowledge in cardiovascular and pulmonary medicine. After acute respiratory distress syndrome associated with COVID-19 and subsequent ICU treatment, most patients suffer from reduced lung function, critical illness polyneuropathy and critical illness myopathy and cardiorespiratory deconditioning. 7 In addition, high prevalence of anxiety and depression has been reported after ICU treatments and hospital admission for COVID-19 might be associated with fear of survival of patient and families. [8] [9] [10] However, as the whole COVID-19 condition is so new, there are scarce data available about feasibility, safety and success of in-patient CR in COVID-19 patients. We hypothesized that CR for COVID-19 is safe and feasible and therefore aimed to characterize patients referred to inpatient rehabilitation and describe performance and outcome during rehabilitation.

The cohort presents patients referred for CR to the Zürcher RehaZentren Wald, Switzerland after hospitalization in acute care hospitals for COVID-19 between March and May 2020. Patients were retrospectively analyzed to describe potential differences, performance and outcome during rehabilitation. Patients were eligible for rehabilitation as soon as they were hemodynamically and respiratory stable (no catecholamine or invasive ventilation) and without the need for permanent monitoring. In the initial phase of the Corona crisis in Switzerland, patients were admitted after being asymptomatic for 2 days and 10 days after onset of infection. Initially patients were admitted after 2 days of no symptoms and 10 days after onset of infection, and later patients were required to have at least one negative swab before transfer.. For these patients isolation was not necessary according to the current guidelines in Switzerland and were cared for on a normal ward. All patients gave written informed consent and local ethics committee approved the study protocol (BASEC-No 2020-01061) .

The cohort was divided into mechanically ventilated patients (n=12) or not ventilated patients (n=16) in the acute hospital setting in order to analyze the impact of very severe COVID-19.

Within two days after admission for rehabilitation all patients were assessed with questionnaires, such as Chronic Respiratory Questionnaire (CRQ), Hospital Anxiety and Depression Scale (HADS), and Cumulative Illness Rating scale (CIRS) and Functional Independence Measure (FIM). To measure changes during rehabilitation, functional assessments with 6-minute walk test (6-MWT) and Feeling Thermometer (FT) were performed on admission and before discharge. All patients were deemed cognitively able to provide valid responses to the questionnaires by treating physicians. Comorbidities, Lung function, and laboratory values including blood gas analysis were assessed.

The patients participated in a multimodal 2-4 weeks inpatient CR, which was carried out according to a protocol adapted to the severity of the disease. This program normally included a total of 25-30 therapy sessions, which took place on 5-6 days per week. It consisted of an individualized exercise training including aerobic exercise and strength training.

Training intensity for aerobic exercise was mainly derived from an initial 6-MWT, only in some patients exercise cycle ergometer tests were performed. The aerobic program consisted primarily of supervised in-and outdoor walking, or stationary cycling. Patient were monitored using pulse oxymetry during their exercise. criteria for stopping or reducing exercise intensity was SpO 2 < 88%, symptom limited (Borg >6) or/and reaching their submaximal heart rate.

Strength training was performed 3 x 20 repetitions with the maximum tolerated load. The intensity of the monitored endurance training sessions was adjusted continuously, with the aim of achieving the maximum tolerated exercise load during each training session. When a drop in oxygen saturation was observed, oxygen was added with a maximum of 4 L via nasal cannula to keep the oxygen saturation at >90%. Respiratory physiotherapy consisted of teaching breath control (pursed lip breathing, secretion mobilization and diaphragmatic breathing), energy saving techniques and controlled coughing exercises. Twice a week (1 h each), all patients participated in educational sessions, which in addition to self-management, included coping skills and nutrition interventions, self-medication, management of infections and exacerbations, dyspnoea, use of oxygen, as well as activities of daily living. To the underweight and overweight patients a nutritional advice and diabetes advice was offered.

If needed the patients took part in a structured smoking cessation program, and received psychosocial support.

Non-invasive ventilation (NIV) using breathing support administered through a face mask in order to reduce the work load of breathing and improve gas exchange was initially used in 3 patients during night time only and not during exercise training.

For the treatment and management of COVID-19 patients, the recommendations of the Swiss Noso (Swiss National Institute of Infection-Prevention) and the Health Department of the Kanton Zurich were applied. An assessment of the hygienic risk was made for the individual patient. If isolation was indicated the patients were transferred to the isolation ward where they were supervised in a single room. The staff in close contact with these patients (especially nursing staff and physiotherapists) had to wear FFP-2 masks, long-sleeved disposable fluid repellent gowns or disposable fluid repellent coveralls, eye protection, and gloves. Temporary isolation was stopped following negative COVID-19 swab. In some cases, the viral RNA was still

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. detected in the PCR although being asymptomatic leading to the continued isolation until at least one test was negative. In isolated patients, individual therapies were carried out 1-2 times a day for 15-45 minutes depending on the level of performance, according to the severity of the illness and were adjusted in the course of time. Therapies took place in the patients room and instructions for self-training were given as well as smaller therapy devices, such as elastic resistance bands and/or breathing training devices such as RC-Cornet ® or VRP1-flutter ® . Some training devices were stored in a central location in the isolation ward and were disinfected after each therapy, such as motorized training devices, stepper, ergometer, etc. Respiratory therapies, psychological support, massages, nutrition and diabetes counselling, social services, etc. were provided. The frequency of these treatments were adapted to the individual and diagnosed limitations and needs of the patients.

Exercise capacity was measured at hospital admission and discharge using the 6-min walk test (6-MWT), performed once at the beginning and once at the end of the CR program after 20 days, according to the guidelines of the American Thoracic Society (ATS) and carried out by experienced, well-instructed examiners. 11

As standardized health-related quality of life (HRQoL) measurement tool, the German version of the Chronic Respiratory Questionnaire (CRQ) was used. The questionnaire measures eight dimensions of HRQoL and allows calculation of two summary scales of physical and mental health. 12

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

The FIM is an 18-item measurement tool that explores an individual's physical, psychological and social function. 13 We used this tool to assess a patient's level of disability as well as change in patient status in response to rehabilitation.

CIRS was used as an indicator of health status and predicted 18-month mortality and rehospitalization especially in hospitalized elderly patients. 14

The HADS was originally designed as a short, easy-to-use, 14-item screening tool for depression and anxiety symptoms in the hospital outpatient setting. 15 It is composed of two 7-item subscales (both ranging from 0 to 21 with higher scores indicating more severe distress.

We used the FT to determine and compare patients' feelings about their actual wellbeing by applying a numeric rating of their feelings toward an imaginary scale in terms of degrees, with their attitudes corresponding to temperatures.

Spirometry and body plethysmography (Master Screen Body; Jaeger GmbH, Hoechberg, Germany) were performed on CR discharge according to recent guidelines. 16 Blood gases were

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. taken at rest under room air condition (Radiometer ABL800, Willich, Germany) at the admission to CR.

Binary variables were presented as frequencies and the Fisher`s exact test was used for groupcomparison. Normally distributed continuous variables were presented as mean with standard deviation (SD) and the T-Test was used for comparison between groups. Not normally distributed continuous variables were presented as median with inter-quartile range (IQR) and

the Mann-Whitney-U-Test was used for group-comparison. P-value <0.05 was considered as statistically significant.

50% were female, mean age was 66 years and duration of stay was 19.3±10.7 days before referral for CR. (Table 1 ) 17 patients (61%) needed ICU treatment and 12 patients needed ventilation in the acute hospital setting with a mean duration of 10.8±6.3 days. Ventilated patients had a longer ICU stay in days (17.0 (5.9) vs 6.4 (3.8); p<0.002) and total duration of the hospitalization in days (27.6 (9.1) vs 12.7 (1.7); p<0.001). All patients performed a CR with a mean duration of 20 days. Partially CR was provided with limited intensity due to hygiene concept and necessary isolation. 21 patients (75%) still needed nasal oxygen therapy and 3 (11%) received non-invasive ventilation (NIV) during the night on admission to CR. None died or had to be retransferred to the acute hospital setting. 85% of the patients were still isolated on admission while 15% of them had least one negative SARS-CoV-2 swab taken in the acute clinic before transfer to the rehabilitation clinic.

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

Risk factors were comparable in both groups according to the comorbidities. At admission to CR CIRS, HADS and FIM scores were similar for the ventilation group in comparison to the nonventilated group. This was also true for the Questionnaires (HADS, CRQ), 6-MWT and FT (Table 1) .

Significant enhancements were observed in 6-MWT (+130m) and FT (+40 points) for total cohort with no significant differences in the intergroup comparison between ventilated and nonventilated patients. (Figure) Chest x-ray was performed in 27 patients before discharge showing persistent bilateral infiltrations in 20 patients (74%). Lung function testing before discharge showed persistent obstructed ventilation in just a few cases but predominantly restricted ventilation and reduced diffusion capacity were observed in most of the patients, without significant differences between both groups (mean FEV1 56% pred (+ 12), mean FEV1%FVC 81% (+ 9), mean TLC 62% pred (+ 8), mean transfer factor of the lung for carbon monoxide 56% pred (+ 12). 7 patients (25%) still required supplemental oxygen at discharge from CR. However, all patients were able to return back home without professional nursing support.

The findings in the laboratory results indicated that patients with previous ventilation had significant higher inflammation markers (CRP, leucocytes) on admission to CR while there were no significant differences between both groups in the level of Creatinin, Hemoglobin, D-Dimere, BGA, and respiratory parameters (Table 1 and Table 2 ).

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

We demonstrated that CR could be performed safely and with beneficial effect in a rehabilitation cohort of COVID-19 patients. All patients with severe COIVD-19 being referred for CR were stable enough to participate in a comprehensive program irrespective of restrictions due to hygiene safety requirements. Functional capacity and subjective health status improved significantly, as assessed by 6-MWT and FT. Interestingly, patients with previous mechanical ventilation showed identical improvements in 6-MWT and FT as patients without ventilation and no major differences in patient's baseline characteristics including risk factors, respiratory parameters and functional measures. However, the intergroup comparison of the 6-MWT showed an increase of 26.9 meters for the ventilated group compared to non-ventilated patients.

Although statistically not relevant, this result was above the minimal important difference of 25m in pulmonary patients. 17 An explanation might be their longer stay in the acute hospital with more time to recover, which possibly also explains the missing difference in the 6-MWT on admission to CR. We would have expected, in contrast to the observation that patients with the lowest initial distance walked in 6-MWT have a higher probability of reaching the minimal important difference. 18 The almost identical improvements in both groups suggest a classic deconditioning rather than the muscle dysfunction that is often discussed in context with COVID-19. At discharge we found in most patients a restricted ventilation according to their lung function which is in line with data from 2005 of 97 SARS survivors, showing in 24% persistent reduction of lung diffusion and exercise capacity at 1-year follow-up. 19 The need for rehabilitation during the COVID-19 pandemic has been published recently. 20 We demonstrate that inpatient CR is apparently feasible and safe in COVID-19 patients, as long as

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

proper safety precautions, close medical management, and supplemental oxygen are available and used if needed.

Like all retrospective analyses, the validity of the data is already limited by the study design itself. Referring the severe and very severe COVID-19 patients to this CR program leads to a one-sided view of COVID-19, which is why the results cannot be transferred to the total cohort of COVID-19 patients, probably leading to a selection bias. Another limitation is the short observation period of an average of 20 days. It is not sure that all patients received exactly the same CR content, as the program had to be varied or limited in some patients due to isolation. In addition, the single-center approach and the lack of a control group limit the validity of the data.

Comprehensive CR following COVID-19 is safe, feasible and effective. Improvements were significant according to physical performance and subjective health status regardless of previous ventilation. Safety issues regarding a strict hygiene concept addressing contact isolation and personal protection equipment was important but could also be implemented within CR. in-house infected, infection occurred during rehabilitation.

*p-value for the comparison with the total group of the extern cohort.

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. 

BGA, blood gas analysis; NIV, non invasive ventilation; extern, referred to CPR; in-house infected, infection occurred during rehabilitation